NCT00441688View on ClinicalTrials.gov

Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

974

Participants

Timeline

Start Date

March 15, 2007

Primary Completion Date

June 1, 2007

Study Completion Date

June 1, 2007

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

GI265235

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY